64 results
8-K
EX-99.1
SAGE
Sage Therapeutics Inc
25 Apr 24
Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
6:46am
zuranolone clinical trials and manufacturing as result of the Q3 2023 restructuring, partially offset by higher spend on dalzanemdor trials
SC TO-C
lhzguj
8 Dec 23
Information about tender offer
9:00am
8-K
EX-99.1
87m4w4susyo jjbj
8 Nov 22
Sage Therapeutics Announces Third Quarter 2022 Financial Results and Highlights Pipeline and Business Progress
6:45am
8-K
EX-99.1
sa5ou
3 May 22
Sage Therapeutics Announces First Quarter 2022 Financial Results and Highlights Pipeline and Business Progress
6:45am
8-K
EX-99.1
uxp94h74oz
24 Feb 22
Sage Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Highlights Pipeline and Business Progress
6:45am
DEFA14A
5hyehgec9d6wanzhd 9l
29 Apr 21
Additional proxy soliciting materials
4:09pm